ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV (GSK) (PFE)
Go back to ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV (GSK) (PFE)| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 40.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.86 | 52 Week High | $45.58 | |||
| Open | $40.86 | 52 Week Low | $37.82 | |||
| Day High | $40.86 | P/E | N/A | |||
| Day Low | $40.86 | EPS | $0.00 | |||
| Volume | 12,531 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.27 | 52 Week High | $37.39 | |||
| Open | $26.27 | 52 Week Low | $28.25 | |||
| Day High | $26.27 | P/E | 15.92 | |||
| Day Low | $26.27 | EPS | $1.65 | |||
| Volume | 102,976 | |||||
